v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 28,624 $ 66,769 $ 47,979 $ 68,348
Operating expenses:        
Research and development 97,807 110,138 193,332 208,400
Selling, general and administrative 104,397 65,721 209,293 123,090
Cost of goods sold 2,731 0 2,891 0
Collaboration cost of sales 2,861 2,416 5,253 3,995
Total operating expenses 207,796 178,275 410,769 335,485
Operating loss (179,172) (111,506) (362,790) (267,137)
Interest and other expense, net (14,654) (11,084) (29,173) (19,952)
Non-cash interest expense on liabilities related to revenue participation right purchase agreements (20,177) (13,181) (38,993) (27,259)
Interest and other income, net 13,941 13,001 24,963 26,702
Change in fair value of derivative liabilities (1,100) 3,000 400 2,600
Change in fair value of liabilities related to RPI Transactions 2,400 (14,600) 800 (10,700)
Net loss $ (198,762) $ (134,370) $ (404,793) $ (295,746)
Net loss per share - basic $ (1.5) $ (1.12) $ (3.17) $ (2.49)
Net loss per share - diluted $ (1.5) $ (1.12) $ (3.17) $ (2.49)
Weighted-average number of shares used in computing net loss per share - basic 132,086 119,457 127,704 118,979
Weighted-average number of shares used in computing net loss per share - diluted 132,086 119,457 127,704 118,979
Other comprehensive (loss) gain:        
Unrealized loss on available-for-sale securities, net $ (1,770) $ (851) $ (3,608) $ (1,392)
Foreign currency translation adjustments (444) (852) (848) (1,164)
Comprehensive loss (200,976) (136,073) (409,249) (298,302)
Net Product Revenue [Member]        
Revenues:        
Total revenues 25,334 0 30,123 0
Collaboration Revenues [Member]        
Revenues:        
Total revenues 3,290 2,416 5,927 3,995
License and Milestone Revenues [Member]        
Revenues:        
Total revenues $ 0 $ 64,353 $ 11,929 $ 64,353